# Adialante

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adialante

- Industry: Medical Devices & Equipment
- Headquarters: San Francisco, US
- Website: adialante.com
- Latest round: Seed (May 25, 2026)
- Investors on record: 2

## About

Adialante™ is a healthcare technology company that develops and operates mobile imaging clinics, offering diagnostic-grade MRI services directly to healthcare providers, thus streamlining patient care and enhancing diagnostic capabilities.Founded in 2023, Adialante, Inc. is headquartered in San Francisco, US. The company focuses on delivering mobile MRI services to clinics, allowing them to perform on-site diagnostic imaging without heavy capital investments. It has completed one deal to date, with its most recent deal occurring on May 25, 2026. The CEO and founder's current information is not available, but details on prior ventures are not cited.Adialante™ specializes in providing a mobile imaging clinic that delivers diagnostic-grade MRI services directly to healthcare practices. The flagship offering enables clinics to perform MRI scans on-site, eliminating the need for significant capital investments or construction. This service streamlines patient care by reducing wait times for imaging; patients can be scanned within hours instead of being referred out. The primary clientele includes urology clinics, sports medicine practices, and various healthcare providers aiming to enhance their diagnostic capabilities. Adialante plans to expand its offerings to additional medical specialties, including breast imaging and neuroimaging, focusing primarily on onboarding practices in the United States.Adialante operates on a per-scan payment model, charging clinics a flat fee for each MRI performed. This structure enables healthcare providers to collect insurance reimbursements while retaining a margin, effectively turning imaging services into a profit center for clinics. Transactions occur on a B2B basis, with healthcare practices partnering with Adialante to integrate mobile MRI services into patient care workflows. As the company rolls out its mobile units, it anticipates priority scheduling benefits for early-access clinics, enhancing service availability and operational efficiencies. The pricing model is transparent, providing clinics with clear financial expectations regarding MRI service costs.In May 2026, Adialante, Inc. raised an undisclosed amount of Seed funding from new investors Pioneer Fund and Y Combinator, alongside participation from an individual investor. The company plans to utilize this funding to accelerate its growth initiatives. Future strategies include the design and launch of new imaging products, while Adialante aims to expand its services into additional markets and geographic regions.

## Funding rounds

- Seed, May 25, 2026 — Y Combinator, Pioneer Fund

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed